After tremendous growth in recent years, today's Swedish biotech industry comprises more than 200 companies. It is Europe's fourth-largest, overall, and the largest when measured in relation to both population and GDP. This success is the result of several factors: a deep tradition in biotech research, strong consolidation in the pharmaceutical sector, booming entrepreneurial activity and access to venture capital.
ISA provides details about Swedish business conditions and investment opportunities.
For further information about Life Sciences & Biotechnology investment in Sweden, please click below:> www.isa.se
or please contact:Emiko TamuraAdvisorLife SciencesE-mail: emiko.tamura@itps.se